Tag Archives: Pharmaceutical companies

Biotech Bad Boy Shkreli Hit With Securities Class Action Lawsuit

I am sure that many of you, like me, felt a satisfying wave of schadenfreude when you heard the news last week that biotech bad boy Martin Shkreli had been arrested on securities fraud charges. Shkreli became the poster-child for drug company price-gouging after his company, Turing Pharmaceuticals, increased the price of Daraprim, a life-saving … Continue Reading

Big Doings in Big Cases: Merck Settle Securities Suits for $688 Million, Facebook IPO Derivative Suits Dismissed

In what may be the largest settlement ever in securities class action litigation involving a pharmaceutical company, Merck has agreed to a combined settlement of $688 million to settle two related securities class action cases. The company’s February 14, 2013 press release announcing the settlements can be found here.   The lawsuits relate to alleged … Continue Reading
LexBlog